Semax + Selank Blend Vial

Selank + Semax Blend is a dual-peptide formulation combining Selank (10mg) and Semax (10mg). This combination is utilised in laboratory research involving peptide interactions, neuropeptide signalling pathways, receptor activity, and multi-compound experimental models.

Selank + Semax is a blended peptide formulation combining two compounds frequently referenced in peptide research literature.

Chemical reference information: Semax 10 mg / CAS number: 80714-61-0; Semax 10 mg / Molecular formula: C₃₇H₅₁N₉O₁₀S; Semax 10 mg / Molecular weight: 813.92 g/mol; Selank 10 mg / CAS number: 129954-34-3; Selank 10 mg / Molecular formula: C₃₃H₅₇N₁₁O₉; Selank 10 mg / Molecular weight: 751.87 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Semax + Selank Blend 20 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Semax 10 mg / CAS number

80714-61-0

Semax 10 mg / Molecular formula

C₃₇H₅₁N₉O₁₀S

Semax 10 mg / Molecular weight

813.92 g/mol

Selank 10 mg / CAS number

129954-34-3

Selank 10 mg / Molecular formula

C₃₃H₅₇N₁₁O₉

Selank 10 mg / Molecular weight

751.87 g/mol

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.